Skip to content

Grow It! Sophia: investigating the Grow It! smartphone app used to identify mood problems and promote adaptive coping in adolescents with a chronic somatic condition

Grow It! Sophia: a smartphone application to identify mood problems and adaptive coping in adolescents with a chronic somatic condition

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17883961
Enrollment
200
Registered
2022-06-27
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic somatic condition Not Applicable

Interventions

Participants are allocated to the experimental or control condition through computer-based, block-wise randomisation. Patients are assigned to blocks based on their chronic somatic condition. Assessme

Sponsors

Stichting Vrienden van Sophia - Lichtjesactie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adolescents (aged 10 - 18 years) undergoing treatment in the Sophia Children's Hospital Rotterdam for a chronic somatic condition (a condition that lasts longer than 3 months, recurs more than three times a year and/or is related to long-term use of medication, treatments or help)

Exclusion criteria

Exclusion criteria: 1. Intellectual disability (IQ <70) 2. Insufficient comprehension and proficiency of the Dutch language

Design outcomes

Primary

MeasureTime frame
Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) and the Children Depression Inventory (CDI) at baseline, after using the app (week 5), after 3 months (condition group T4 and T5)

Secondary

MeasureTime frame
1. Quality of life is measured using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales at baseline, after 5 weeks and after 3 months (condition group T4 and T5) 2. Self-esteem is measured using the Rosenberg Self-Esteem Scale (RSES) at baseline, after 5 weeks and after 3 months (condition group T4 and T5) 3. Illness perception is measured using the Brief Illness Perception Questionnaire (B-IPQ) at baseline, after 5 weeks and after 3 months (condition group T4 and T5) 4. Emotional and behavioural problems are measured using the Child behaviour Checklist (CBCL) at baseline, after 5 weeks and after 3 months 5. Sleep quality and quantity are measured using a self-developed scale based on prior studies for 28 days once a day 6. Emotions are measured using a test based on the Positive and Negative Affect Schedule (PANAS) for 28 days, 5 times a day 7. Fatigue, loneliness and worry are measured using a self-developed scale based on prior studies for 28 days, 5 times a day 8. Physical pain is measured using the Numerical Rating Scale (NRS) for 28 days, 5 times a day 9. Events are measured using a self-developed scale based on prior studies for 28 days, 5 times a day 10. Coping is measured using a self-developed scale based on Fragebogen zur Erhebung der Emotionsregulation bei Kindern und Jugendlichen (FEEL-KJ), Emotion Regulation Questionnaire (ERQ), Cognitive Emotion Regulation Questionnaire (CERQ) and UCL for 28 days, once a day 11. Exercise questions are measured using a self-developed scale based on prior studies for 28 days, once a day 12. Medication adherence is measured using a self-developed question for 28 days, 5 times a day 13. Health status is measured using a self-developed scale for 28 days, 5 times a day

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026